slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 235,831-235,860
Pages 10,126
Rows per page 30
Component
235,831-235,860 of 303,780
23
Moelis & Company | Investor Presentation Deck | 24 slidesMoelis & Company | Investor Presentation Deck | 24 slides · Moelis
Pitch deck Investor relations 1 hit
24
Includes footnotes explaining specific reclassifications related to MA Financial Group shares and employee compensation.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Pitch deck Investor relations 1 hit
01
NeuroSense Therapeutics | Investor Presentation Deck | 27 slidesNeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
02
NeuroSense Therapeutics | Investor Presentation Deck | 27 slidesNeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
03
The slide uses a five-column icon-based layout to present key value propositions.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
05
NeuroSense Therapeutics | Investor Presentation Deck | 27 slidesNeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
06
The slide uses a grid layout to showcase the board members with headshots, credentials, and associated logos.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
07
Uses a 'before and after' visual comparison of a patient's health progression over time.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Problem Statement1 hit
08
The slide uses a three-column layout to explain the biological mechanisms of the drug combination.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
09
The slide shows a pharmacokinetic study in mice comparing Ciprofloxacin alone vs. combination therapy.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
10
Includes statistical significance markers (*, ***) and source citation.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
11
Includes a collaboration credit with Dr. Justin Ichida at USC.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
12
Includes box plots for baseline comparison and line charts for longitudinal treatment effects.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
13
Includes a flow diagram of the trial phases and a table of baseline characteristics.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
14
The slide highlights safety data; the bottom text emphasizes that adverse events were transient and anticipated.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
15
Includes statistical significance markers and sample sizes (N) for each time point.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
16
Includes both a longitudinal line chart and a bar chart comparing total points lost at 12 months.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
17
The slide compares 'DB' (Double Blind) and 'DB+OLE' (Double Blind + Open Label Extension) periods across four functional domains.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
18
The slide notes 'n.s.' (not statistically significant) for all metrics. The footer defines SVC and Survival calculation methodology.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
19
Includes longitudinal biomarker charts and correlation scatter plots with p-values.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
20
The slide uses a bulleted list to present key clinical trial outcomes, including p-values and percentage improvements.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
21
KOL = Key Opinion LeaderNeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
22
NeuroSense Therapeutics | Investor Presentation Deck | 27 slidesNeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Market Sizing1 hit
24
NeuroSense Therapeutics | Investor Presentation Deck | 27 slidesNeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
25
The slide uses a list of four key value propositions for the drug candidate PrimeC.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
26
The slide uses emotional appeal to establish credibility and mission alignment.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
01
Includes company logo GDEV and copyright 2024.Nexters | Investor Presentation Deck | 40 slides · GDEV
Pitch deck Investor relations 1 hit
02
Includes detailed footnotes regarding data sources and definitions.Nexters | Investor Presentation Deck | 40 slides · GDEV
Pitch deck Investor relations 1 hit
03
Nexters | Investor Presentation Deck | 40 slidesNexters | Investor Presentation Deck | 40 slides · GDEV
Pitch deck Investor relations 1 hit
04
Includes a line chart showing bookings growth over time and specific KPIs for individual games.Nexters | Investor Presentation Deck | 40 slides · GDEV
Pitch deck Investor relations Beat · Product1 hit